DrugPatentWatch Database Preview
CEREZYME Drug Profile
Email this page to a colleague
» See Plans and PricingSummary for Tradename: CEREZYME
| Patents: | 41 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for CEREZYME |
| Recent Clinical Trials: | See clinical trials for CEREZYME |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CEREZYME |
Recent Clinical Trials for CEREZYME
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Sanofi | N/A |
| National Taiwan University Hospital | N/A |
| Sanofi | Phase 3 |
Recent Litigation for CEREZYME
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| MiMedx Group, Inc. v. Tissue Transplant Technology, Ltd. | 2014-05-16 |
Company Disclosures: US Patents for CEREZYME
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | Genzyme Corporation (Cambridge, MA) | 2010-08-17 | RX | company | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | Genzyme Corporation (Cambridge, MA) | 2013-08-27 | RX | company | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 002 | 1995-04-07 | Start Trial | Genzyme Corporation (Cambridge, MA) | 2010-08-17 | RX | company | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 002 | 1995-04-07 | Start Trial | Genzyme Corporation (Cambridge, MA) | 2013-08-27 | RX | company | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for CEREZYME
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | The Hospital for Sick Children (Ontario, CA) McMaster University (Ontario, CA) | 2027-09-17 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | Amicus Therapeutics, Inc. (Cranbury, NJ) | 2029-10-19 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | Orphazyme A/S (Copenhagen N, DK) | 2028-06-26 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | The Hospital for Sick Children (Toronto, Ontario, CA) McMaster University (Hamilton, Ontario, CA) | 2027-09-17 | RX | search | |
| Genzyme | CEREZYME | imiglucerase | INJECTABLE;INJECTION | 020367 | 001 | 1995-04-07 | Start Trial | Selecta Biosciences, Inc. (Watertown, MA) | 2033-05-03 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for CEREZYME
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 378270 | Start Trial |
| China | 104428009 | Start Trial |
| Eurasian Patent Organization | 003665 | Start Trial |
| Brazil | 9812693 | Start Trial |
| Japan | 2003513031 | Start Trial |
| Russian Federation | 2011147216 | Start Trial |
| Norway | 20074267 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CEREZYME
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C300722 | Netherlands | Start Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| 122015000021 | Germany | Start Trial | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| 92678 | Luxembourg | Start Trial | PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725 |
| C01280520/01 | Switzerland | Start Trial | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012 |
| 14/2015 | Austria | Start Trial | PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720 |
| CA 2015 00017 | Denmark | Start Trial | PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720 |
| 300722 | Netherlands | Start Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
